Cargando…

Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

Detalles Bibliográficos
Autores principales: Lima, Keli, Vicari, Hugo Passos, Carlos, Jorge Antonio Elias Godoy, da Silva, Jean Carlos Lipreri, Figueiredo-Pontes, Lorena Lobo de, Rego, Eduardo Magalhães, Machado-Neto, João Agostinho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885367/
https://www.ncbi.nlm.nih.gov/pubmed/33753045
http://dx.doi.org/10.1016/j.htct.2021.01.004
_version_ 1784660400228270080
author Lima, Keli
Vicari, Hugo Passos
Carlos, Jorge Antonio Elias Godoy
da Silva, Jean Carlos Lipreri
Figueiredo-Pontes, Lorena Lobo de
Rego, Eduardo Magalhães
Machado-Neto, João Agostinho
author_facet Lima, Keli
Vicari, Hugo Passos
Carlos, Jorge Antonio Elias Godoy
da Silva, Jean Carlos Lipreri
Figueiredo-Pontes, Lorena Lobo de
Rego, Eduardo Magalhães
Machado-Neto, João Agostinho
author_sort Lima, Keli
collection PubMed
description
format Online
Article
Text
id pubmed-8885367
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-88853672022-03-04 Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax Lima, Keli Vicari, Hugo Passos Carlos, Jorge Antonio Elias Godoy da Silva, Jean Carlos Lipreri Figueiredo-Pontes, Lorena Lobo de Rego, Eduardo Magalhães Machado-Neto, João Agostinho Hematol Transfus Cell Ther Letter to the Editor Sociedade Brasileira de Hematologia e Hemoterapia 2022 2021-03-13 /pmc/articles/PMC8885367/ /pubmed/33753045 http://dx.doi.org/10.1016/j.htct.2021.01.004 Text en © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Lima, Keli
Vicari, Hugo Passos
Carlos, Jorge Antonio Elias Godoy
da Silva, Jean Carlos Lipreri
Figueiredo-Pontes, Lorena Lobo de
Rego, Eduardo Magalhães
Machado-Neto, João Agostinho
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
title Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
title_full Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
title_fullStr Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
title_full_unstemmed Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
title_short Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
title_sort obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885367/
https://www.ncbi.nlm.nih.gov/pubmed/33753045
http://dx.doi.org/10.1016/j.htct.2021.01.004
work_keys_str_mv AT limakeli obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax
AT vicarihugopassos obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax
AT carlosjorgeantonioeliasgodoy obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax
AT dasilvajeancarloslipreri obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax
AT figueiredoponteslorenalobode obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax
AT regoeduardomagalhaes obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax
AT machadonetojoaoagostinho obatoclaxreducescellviabilityofacutemyeloidleukemiacelllinesindependentlyoftheirsensitivitytovenetoclax